• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Off-Label Use (1494)
Patient Problems Thrombus (2101); Patient Problem/Medical Problem (2688)
Event Date 10/30/2018
Event Type  Injury  
Manufacturer Narrative
No components from the venaseal closure system kit or sonographic images were received for evaluation.Five photographic images on five consecutive off-visits of the patient¿s symptoms were received for evaluation.The images are of the patient¿s right lower limb just above the medial malleolus.On (b)(6) 2018 a pinkish pimple is observed just above the medial malleolus.On (b)(6) 2018 swelling and expanded area of redness is noted in the area just above the medial malleolus.On (b)(6) 2018 the skin appears to have hardened, the coloration has darkened, and the skin is beginning to peel.On (b)(6) 2018 the swelling has receded, the skin appears rough, and a black crust on a superficial sore has formed.On (b)(6) 2018 the area of redness has reduced in size, the skin in the vicinity of the superficial sore is rough, and the black crust on the sore has thickened.On (b)(6) 2018 the swelling continues to recede and the black crust on superficial sore remains.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that a patient was treated off label with vena seal (vs) adhesive only in the ankle perforator vein, near the medial malleolus.The patient developed a very small thrombus in the untreated segment of the gsv approx 3+ inches from the perforator treatment zone.This then developed into a necrotic erosive lesion.The nurse practioner does not believe it is associated with the vs treatment, but is most likely the result of a spider bite.There was no venaseal adhesive in or near the lesion.No further patient complications have been reported as a result of this event.Patient is receiving conservative wound treatment and will be monitored.
 
Manufacturer Narrative
Implant date reported (b)(6) 2018 is incorrect.Date of impant is not known.Additional information received: patient was referred to a wound care md after (b)(6) 2018.Physician is confident the wound was from a spider bite, possibly brown recluse.No further information available.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8105188
MDR Text Key128385677
Report Number9612164-2018-03359
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/30/2018
Initial Date FDA Received11/27/2018
Supplement Dates Manufacturer Received12/14/2018
Supplement Dates FDA Received01/08/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-